Health will finance a drug that reduces cholesterol with two doses a year

by archynewsy
0 comment

He Ministry of Health has approved financing in the National Health System for the first and only treatment that provides an effective and sustained reduction in cholesterol with two doses a year.

As reported by the pharmacist Novartis, inclisiranthe active ingredient of Leqvialready approved in Europe, provides an effective and sustained reduction in cholesterol in 54% of patients with atherosclerotic cardiovascular disease, added to the maximum tolerated dose of statins and with maintenance administration using subcutaneous injection twice a year.

The drug interferes with RNA and limits the production of LDL (bad cholesterol) levels. With its administration, patients with hypercholesterolemia can regulate their blood cholesterol levels below 100 mg/dl.

Cholesterol is a natural fat that circulates through the blood, but if levels are higher than 200 mg/dl it can cause cardiovascular diseases.

In Spain, cardiovascular diseases are the leading cause of death. According to data from the INE, 119,196 people died in 2021 due to these diseases, 26.4% of the total deaths.

Related Posts

Leave a Comment